Marshall Wace, LLP Integra Lifesciences Holdings Corp Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 26,709 shares of IART stock, worth $767,349. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,709
Previous 11,387
134.56%
Holding current value
$767,349
Previous $495,000
91.11%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding IART
# of Institutions
294Shares Held
69.9MCall Options Held
20.2KPut Options Held
9.3K-
Vanguard Group Inc Valley Forge, PA6.98MShares$201 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$191 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.92MShares$170 Million0.05% of portfolio
-
Morgan Stanley New York, NY4.91MShares$141 Million0.01% of portfolio
-
Eaton Vance Management Boston, MA4.22MShares$121 Million0.26% of portfolio
About INTEGRA LIFESCIENCES HOLDINGS CORP
- Ticker IART
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 83,518,200
- Market Cap $2.4B
- Description
- Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...